Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial.
Year: 2025
Type: article
Source: Apollo (University of Cambridge)
Authors: Abdel Jawad, Mohammad, Furtado, Remo HM, Esterline, Russell, Oscarsson, Jan, Gasparyan, Samvel B, Koch, Gary G, Martinez, Felipe, Mukhtar, Omar, Verma, Subodh, Langkilde, Anna Maria, Ambery, Philip, Patel, Shachi, Gosch, Kensey, Windsor, Sheryl L, Soares, Ronaldo VP, Moia, Diogo DF, Aboudara, Matthew, Javaheri, Ali, Saraiva, JF Kerr, Maia, Lilia Nigro, Berwanger, Otavio, Sauer, Andrew J, Kosiborod, Mikhail N
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108002381
FWCI:
Cites:
Cited by:
Related to: